Skip to main content
. 2024 Oct 18;6(5):dlae163. doi: 10.1093/jacamr/dlae163

Figure 1.

Figure 1.

Timeline of diagnostic and therapeutic management. D, Day; DAL, dalbavancin; Cr, residual concentration (mg/L); R, resistant; S, susceptible.